Oncocyte CorporationOncocyte CorporationOncocyte Corporation

Oncocyte Corporation

No trades
See on Supercharts
Market capitalization
‪20.68 M‬USD
−23.74USD
‪−27.78 M‬USD
‪1.50 M‬USD
‪7.57 M‬
Beta (1Y)
1.99

About Oncocyte Corporation

CEO
Joshua Riggs
Headquarters
Irvine
Employees (FY)
46
Founded
2009
ISIN
US68235C2061
FIGI
BBG008P5VFV1
OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OCX is 2.50 USD — it has decreased by 2.34% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Oncocyte Corporation stocks are traded under the ticker OCX.
Oncocyte Corporation is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
OCX stock is 2.81% volatile and has beta coefficient of 1.99. Check out the list of the most volatile stocks — is Oncocyte Corporation there?
One year price forecast for Oncocyte Corporation has a max estimate of 5.00 USD and a min estimate of 3.60 USD.
OCX earnings for the last quarter are −0.81 USD per share, whereas the estimation was −1.01 USD resulting in a 19.67% surprise. The estimated earnings for the next quarter are −0.70 USD per share. See more details about Oncocyte Corporation earnings.
Oncocyte Corporation revenue for the last quarter amounts to ‪429.00 K‬ USD despite the estimated figure of ‪312.50 K‬ USD. In the next quarter revenue is expected to reach ‪225.00 K‬ USD.
Yes, you can track Oncocyte Corporation financials in yearly and quarterly reports right on TradingView.
OCX stock has fallen by 21.88% compared to the previous week, the month change is a 15.25% fall, over the last year Oncocyte Corporation has showed a 58.33% decrease.
OCX net income for the last quarter is ‪−15.99 M‬ USD, while the quarter before that showed ‪−6.49 M‬ USD of net income which accounts for −146.45% change. Track more Oncocyte Corporation financial stats to get the full picture.
Today Oncocyte Corporation has the market capitalization of ‪20.68 M‬, it has decreased by 1.02% over the last week.
No, OCX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OCX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Oncocyte Corporation stock right from TradingView charts — choose your broker and connect to your account.
OCX reached its all-time high on Jan 5, 2016 with the price of 204.80 USD, and its all-time low was 2.08 USD and was reached on Nov 8, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has 46.00 employees. See our rating of the largest employees — is Oncocyte Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Oncocyte Corporation technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Oncocyte Corporation stock shows the sell signal. See more of Oncocyte Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Oncocyte Corporation future price: according to them, OCX price has a max estimate of 5.00 USD and a min estimate of 3.60 USD. Read a more detailed Oncocyte Corporation forecast: see what analysts think of Oncocyte Corporation and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Oncocyte Corporation EBITDA is ‪−20.61 M‬ USD, and current EBITDA margin is ‪−1.37 K‬%. See more stats in Oncocyte Corporation financial statements.